跳到主要內容
:::

邱泰然

高雄長庚醫院 血液腫瘤科主治醫師

血液腫瘤科

肺癌、大腸直腸癌、膽胰癌

教職 : 副教授

醫師網路掛號

※直接點選進入醫師網路掛號畫面※

語言

  • 國語,英語,閩南語

現職

  • 高雄長庚醫院 血液腫瘤科主治醫師

學歷

  • 高雄醫學大學醫學系畢業

經歷

  • 高雄榮民總醫院 實習醫師
  • 高雄醫學大學附設醫院 內科部住院醫師
  • 高雄長庚醫院 內科部住院醫師
  • 高雄長庚醫院 血液腫瘤科住院醫師

學會與認證

  • 中華民國癌症醫學會
  • 台灣內科醫學會

論文及期刊發表

  • Tai-Jan Chiu. Notch3 expression affects aggressive phenotypes of pancreatic ductal adenocarcinoma.
  • Comparison of Fungal and Non-Fungal Rhinosinusitis by Culture-Based Analysis. J Pers Med. 2023 Sep 11;13(9):1368. doi: 10.3390/jpm13091368 (SCI;IF=3.4; Health care 41/106)
  • Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma. Cancer Cell Int. 2023 Sep 24;23(1):212. doi: 10.1186/s12935-023- 03060-z (SCI;IF=5.8; Oncology 60/242)
  • Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients. Otolaryngol Head Neck Surg. 2023 Sep 20. doi: 10.1002/ohn.51 (SCI;IF=3.4; Otorhinolaryngology 5/4311)
  • Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells. Am J Cancer Res. 2023 Apr 15;13(4):1209-1239. eCollection 2023 (SCI;IF=5.3; Oncology 70/242)
  • Safety and effectiveness of transdermal buprenorphine in cancer pain: An observational study in Taiwan (SOOTHE). Asia Pac J Clin Oncol. 2023 Apr;19(2):e45-e53. doi: 10.1111/ajco.13772 (SCI;IF=1.9; Oncology 214/242)
  • Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer. Cancers (Basel). 2023 Feb 5;15(4):1008. doi: 10.3390/cancers15041008
  • The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma. Am J Cancer Res. 2022 Nov 15;12(11):5062-5073. eCollection 2022 (SCI;IF=5.3; Oncology 70/242)
  • Predictive value of albumin combined with neutrophil-to- lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin. Am J Cancer Res. 2022 Sep 15;12(9):4267-4278. eCollection 2022 (SCI;IF=5.3; Oncology 70/242)
  • Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study. Front Oncol. 2022 Aug 29;12:952616. doi: 10.3389/fonc.2022.952616. eCollection 2022 (SCI;IF=4.7; Oncology 85/242)
  • Clinical Characteristics and Predictive Outcomes of Recurrent Nasopharyngeal Carcinoma-A Lingering Pitfall of the Long Latency. Cancers (Basel). 2022 Aug 4;14(15):3795. doi: 10.3390/cancers14153795. (SCI;IF=5.2; Oncology 71/242)
  • Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study. Front Oncol. 2022 Jun 22;12:800842. doi: 10.3389/fonc.2022.800842. eCollection 2022 (SCI;IF=4.7; Oncology 85/242)
  • Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis. J Exp Clin Cancer Res. 2022 Jul 1;41(1):215. doi: 10.1186/s13046-022-02415-0. (SCI;IF=11.3; Oncology 25/242)
  • Leptin Silencing Attenuates Lipid Accumulation through Sterol Regulatory Element-Binding Protein 1 Inhibition in Nasopharyngeal Carcinoma. Int J Mol Sci. 2022 May 20;23(10):5700. doi: 10.3390/ijms23105700. (SCI;IF=5.6; Biochemistry & molecular biology 65/285)
  • The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan. Am J Cancer Res. 2022 Apr 15;12(4):1884-1898. eCollection 2022 (SCI;IF=5.3; Oncology 70/242)
  • Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin. J Hepatobiliary Pancreat Sci. 2022 Jun;29(6):670-681. doi: 10.1002/jhbp.1128. Epub 2022 Mar 2. (SCI;IF=3; Surgery 58/212)
  • Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers. Cancers (Basel). 2022 Jan 29;14(3):703. doi: 10.3390/cancers14030703 (SCI;IF=5.2; Oncology 71/242)
  • Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients`experience within a population-based study. Ther Adv Med Oncol. 2021 Nov 20;13:17588359211058255. doi: 10.1177/17588359211058255. eCollection 2021 (SCI;IF=4.9; Oncology 78/242)
  • Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study. PLoS One 2021 Dec 2;16(12):e0260772. (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)
  • Nanoliposomal Irinotecan Pre-Emptive Dose Reduction in Patients with Pancreatic Ductal Adenocarcinoma: 667 Patients’ Experience within a Population-Based Study. Therapeutic Advances in Medical Oncology . 2021 Nov 20;13:17588359211058255. doi: 10.1177/17588359211058255. (SCI;IF=4.9; Oncology 78/242)
  • Downregulation of Notch3 links TIMP3 inhibition to suppress aggressive phenotypes of pancreatic ductal adenocarcinoma, American Journal of Cancer Research (SCI;IF=5.3; Oncology 70/242)
  • Development and Validation of a Novel Serum Predictive Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment. Cancers 2021, 13, 5080. (SCI;IF=5.2; Oncology 71/242)
  • Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma. J Clin Med. 2021 Sep 12;10(18):4118 (SCI;IF=3.9; Medicine, General&internal 58/170)
  • Sex Differences in Otolaryngology: Focus on the Emerging Role of Estrogens in Inflammatory and Pro-Resolvin Responses. Int J Mol Sci. 2021 Aug 16;22(16):8768. doi: 10.3390/ijms22168768. (SCI;IF=5.6; Biochemistry & molecular biology 65/285)
  • Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma. Sci Rep. 2021 Aug 25;11(1):17161. doi: 10.1038/s41598-021-96614-y (SCI;IF=4.6; Multidisciplinary sciences 21/73)
  • Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice. Front Oncol. 2020 Nov 27;10:584834. doi: 10.3389/fonc.2020.584834. eCollection 2020(SCI;IF=4.7; Oncology 85/242)
  • Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular–cholangiocarcinoma PLoS One. 2020 Dec 11;15(12):e0240791. doi: 10.1371/journal.pone.0240791. eCollection 2020. (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)
  • The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/Hypopharyngeal Cancer Treated by Chemoradiation/Radiation. Cancer Manag Res. 2020 Sep 25;12:9013-9021. doi: 10.2147/CMAR.S275635. (SCI;IF=3.3; Oncology 135/242)
  • Predictors of hospital expenses and hospital stay among patients undergoing total laryngectomy: Cost effectiveness analysis. PLoS One. 2020 Jul 16;15(7):e0236122. doi: 10.1371/journal.pone.0236122. eCollection 2020. (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)
  • Inactivation of APC Induces CD34 Upregulation to Promote Epithelial- Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer. Int J Mol Sci. 2020 Jun 23;21(12): E4473. doi: 10.3390/ijms21124473. (SCI;IF=5.6; Biochemistry & molecular biology 65/285)
  • Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan. Cancers (Basel). 2020 Jun 12;12(6):E1551. doi: 10.3390/cancers12061551. (SCI;IF=5.2; Oncology 71/242)
  • Pancreatic stellate cells activated by mutant KRAS- mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8. Theranostics. 2019 Sep 23;9(24):7168-7183. doi: 10.7150/thno.36830. eCollection 2019. (SCI;IF=12.4; MEDICINE, RESEARCH & EXPERIMENTAL 8/136)
  • Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer. Cancer Cell. 2018 Dec 10;34(6):954-969.e4. doi: 10.1016/j.ccell.2018.11.007. (SCI;IF=50.3; Cell Biology 4/191)
  • Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy. Biomed Res Int. 2018 Apr 30;2018:9098215. doi: 10.1155/2018/9098215. (SCI;IF=3.246; Biotechnology &applied microbiology 89/162)
  • Oncogenic Fibulin-5 SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma. J Cardiothorac Surg. 2018 Apr 10;13(1):25. (SCI;IF=1.6; Surgery 146/213)
  • SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma. J Cardiothorac Surg. 2018 Apr 10;13(1):25. (SCI;IF=1.6; CARDIAC & CARDIOVASCULAR SYSTEMS 119/143)
  • Combinatorial Methods of Immunotherapy Open New Opportunities in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Review article. International Journal of Head and Neck Science 2(1): 5-13, 2018. (non-SCI)
  • Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma. BMC Cancer. 2018 Feb 27;18(1):227. (SCI;IF=3.8; Oncology 109/242)
  • High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy. Mol Med Rep. 2017 Nov;16(5):7185- 7190. doi: 10.3892/mmr.2017.7555. (SCI;IF=3.2; Surgery 47/213)
  • Treatment Outcome of Patients with Unresectable Stage IVB Head and Neck Squamous Cell Carcinoma Receiving Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil. International Journal of Head and Neck Science 1(2): 121-130, 2017 (non-SCI)
  • Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A. Sci Rep. 2017 May 2;7(1):1358. (SCI;IF=4.6; Multidisciplinary sciences 21/73)
  • The Therapeutic Benefit of Radical Resection for T4b Oral Cavity Squamous Cell Carcinoma with Partial or Complete Response After Radical Chemo-Intensity-Modulated Radiotherapy (IMRT). Ann Surg Oncol. 2016 Dec;23(Suppl 5):866-873. (SCI;IF=3.7; Surgery 26/213)
  • Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. World J Surg Oncol. 2016 Mar 22;14:86. (SCI;IF=3.2; Surgery 47/213)
  • Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. Head Neck. Head Neck. 2016 Apr;38 Suppl 1:E844-52. (SCI;IF=2.9;Otorhinolaryngology 8/43)
  • Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. Mol Cancer. 2015 Oct 12;14(1):179. (SCI;IF=5.43; BIOCHEMISTRY & MOLECULAR BIOLOGY 4/285)
  • Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma, BioMed Research international 2015; 2015: 508587. (SCI;IF=3.246; BIOTECHNOLOGY & APPLIED MICROBIOLOGY 90/159)
  • Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer. Mol Cancer. 2015 Apr 12;14:83. (SCI;IF=5.43; BIOCHEMISTRY & MOLECULAR BIOLOGY 4/285)
  • Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis. PLoS One. 2013 Dec 27;8(12):e84218 (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)
  • Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma. Biomarkers. 2013 Oct 28. (SCI;IF=2.6; BIOTECHNOLOGY & APPLIED MICROBIOLOGY 108/158)
  • Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers. Exp Ther Med. 2012 Aug;4(2):231-236. (SCI;IF=2.7; MEDICINE, RESEARCH & EXPERIMENTAL 92/136)
  • Pemetrexed as third-line chemotherapy for locally advanced and metastatic non-small cell lung cancer (NSCLC) : A retrospective analysis.2011;27:157-164. (non-SCI)
  • High p16 expression predicts a positive response to chemoradiotherapy in stage IVa/b head and neck squamous cell carcinoma. Asian Pac J Cancer Prev. 2011;12(3):649-55 (non-SCI)
  • High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area.J Transl Med. 2011 Mar 23;9:31 (SCI;IF=7.4; MEDICINE, RESEARCH & EXPERIMENTAL 29/136)
  • Metastatic Mucinous Colorectal Cancer: An Important Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Survival. J. Cancer Res. Pract. 26( 6), 221 - 230, 2010 (non-SCI)
  • Impact of Comorbidity on Survival for Locally Advanced Head and Neck Cancer Patients Treated by Radiotherapy or Radiotherapy plus Chemotherapy. Chang Gung Med J. 2010 May-June;33(3):283-291. (non-SCI)
  • Intraarterial Cisplatin and intravenous adriamyc in in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan. Chang Gung Med J. 2009 Jan-Feb;32(1):72-80. (non-SCI)
  • Massive anterior chest wall metastasis of ovarian cancer and prolonged survival after treatment: a case report. J Reprod Med. 2008 May;53(5):373-7. (non-SCI)
長庚醫院智能服務 有任何問題隨時找我!